Table: Fuji Pharmaceutical -Q1 group results

Fuji Pharma

04/02/2021 07:30

Feb 4 (Reuters)- 
             Fuji Pharmaceutical  Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Dec 31, 2020        Dec 31, 2019     Sep 30, 2021 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             9.30                8.97             34.70    
                 (+3.6 pct)          (-12.7 pct)      (+2.7 pct)  
  Operating         1.70                1.05              2.86    
                 (+61.2 pct)         (-34.4 pct)      (-9.0 pct)  
  Recurring         1.73                1.09              2.81    
                 (+59.6 pct)         (-29.1 pct)      (-5.9 pct)  
  Net               1.33               745 mln            2.10    
                 (+78.3 pct)         (-32.0 pct)      (+0.7 pct)  
  EPS             42.64 yen           23.92 yen        67.40 yen  
  Ann Div                             29.00 yen        29.00 yen  
  -Q2 div                             14.00 yen        14.00 yen  
  -Q4 div                             15.00 yen        15.00 yen  
  
  NOTE - Fuji Pharmaceutical  Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4554.T